Clinical Trials
All Clinical Trials - Page 39 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02553603Phase 1Completed
The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment
Tesamorelin
- NCT04555824Phase 1Completed
A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers
TB-500
- NCT03208881N/AUnknown
Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness
Liraglutide
- NCT03179995Phase 2Terminated
Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy
Octreotide
- NCT03098797Phase 2/Phase 3Completed
A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome
Elamipretide
- NCT03083210Phase 4Unknown
Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET
Lanreotide
- NCT03136003Phase 4Unknown
DDAVP vs. Exercise in Patients With Mild Hemophilia A
Desmopressin
- NCT03151005Phase 4Completed
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
Liraglutide
- NCT03197012EARLY_Phase 1Completed
Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor
Octreotide
- NCT03043664Phase 1/Phase 2Completed
Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors
Lanreotide
- NCT03232476Phase 4Withdrawn
Effect of Mechanical Loading With PTH on Cortical Bone
Teriparatide
- NCT02907918Phase 2Terminated
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
Gonadorelin
- NCT03175211Phase 1Completed
Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers
Survodutide
- NCT04129255Phase 2Completed
Octreotide LAR in the Induction of Immunologic Response in NENs Patients
Octreotide
- NCT03191396Phase 3Completed
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
Semaglutide
- NCT03130426Phase 3Completed
Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
Lixisenatide
- NCT03204396Phase 2Completed
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
Dulaglutide
- NCT02993926N/ACompleted
A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants
Gonadorelin
- NCT03115424Phase 3Completed
Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
Liraglutide
- NCT03007979Phase 2Completed
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer
Gonadorelin
- NCT02824718Phase 2Completed
Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism
Teriparatide
- NCT03115099Phase 1Completed
A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes
Liraglutide
- NCT03172494Phase 3Completed
A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)
Liraglutide
- NCT03175120Phase 3Completed
A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
Liraglutide
- NCT03131687Phase 2Completed
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
Tirzepatide
- NCT03167411Phase 1Completed
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
Exenatide
- NCT03048578Phase 4Completed
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
Liraglutide
- NCT02803918Phase 1Completed
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Lixisenatide
- NCT03133195Phase 3Completed
The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA
Teriparatide
- NCT03001349EARLY_Phase 1Terminated
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
Octreotide
- NCT03000946Phase 3Completed
Prevention of Postoperative Pancreatic Fistula by Somatostatin
Octreotide
- NCT03012594Phase 2Completed
Lanreotide in the Treatment of Small Bowel Motility Disorders
Lanreotide
- NCT02960659Phase 1/Phase 2Completed
Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
Liraglutide
- NCT03044977EARLY_Phase 1Active Not Recruiting
Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors
Octreotide
- NCT03101930Phase 4Completed
Cardiovascular Effects of GLP-1 Receptor Activation
Liraglutide
- NCT03072147Phase 2Completed
Teriparatide as a Chondroregenerative Therapy in OA
Teriparatide
- NCT02972424Phase 2Completed
PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
Teriparatide
- NCT03085095Phase 3Completed
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Gonadorelin
- NCT03017690N/ACompleted
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Octreotide
- NCT03082885N/ACompleted
The Efficacy and Safety of Thymosin-α1 in Patients With HBV-related ACLF
Thymosin-Alpha-1
- NCT03070886Phase 2/Phase 3Active Not Recruiting
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery
Gonadorelin
- NCT03112694N/ACompleted
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Octreotide
- NCT02953665Phase 2Completed
Safety and Efficacy of Liraglutide in Parkinson's Disease
Liraglutide
- NCT03824002Phase 4Completed
Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
Dulaglutide
- NCT03103009Phase 1Completed
Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia
Octreotide
- NCT03007329Phase 4Completed
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
Exenatide
- NCT02683941Phase 3Terminated
Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours
Lanreotide
- NCT02964247Phase 3Completed
LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
Liraglutide
- NCT03060980Phase 3Terminated
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Exenatide
- NCT03169166Phase 4Completed
The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies
Gonadorelin